| 12398187 |
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
James Barnaby Trager, Luxuan Guo Buren, Chao Guo, Mira Tohmé, Alexandra Leida Liana Lazetic |
2025-08-26 |
| 12012458 |
Genetically modified natural killer cells for CD70-directed cancer immunotherapy |
James Barnaby Trager, Alexandra Leida Liana Lazetic, Chao Guo, Katherine Jamboretz |
2024-06-18 |
| 11814679 |
Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of same |
John Brian Mumm, Scott McCauley, Scott Ogg, Martin Oft |
2023-11-14 |
| 11413332 |
Methods of using interleukin-10 for treating diseases and disorders |
John Brian Mumm, Martin Oft |
2022-08-16 |
| 11253547 |
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
James Barnaby Trager, Luxuan Guo Buren, Chao Guo, Mira Tohmé, Alexandra Leida Liana Lazetic |
2022-02-22 |
| 11154575 |
Cancer immunotherapy using CD19-directed chimeric antigen receptors |
James Barnaby Trager, Luxuan Guo Buren, Chao Guo, Mira Tohmé, Alexandra Leida Liana Lazetic |
2021-10-26 |
| 11141436 |
Immune cells engineered to express CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
James Barnaby Trager, Luxuan Guo Buren, Chao Guo, Mira Tohmé, Alexandra Leida Liana Lazetic |
2021-10-12 |
| 10618970 |
Method of treating cancer with IL-10 and antibodies that induce ADCC |
John Brian Mumm |
2020-04-14 |
| 10398761 |
Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers |
John Brian Mumm |
2019-09-03 |
| 10293043 |
Methods of lowering serum cholesterol |
John Brian Mumm |
2019-05-21 |
| 10195274 |
Method of modulating a chimeric antigen receptor t cell immune response by administering IL-10 |
John Brian Mumm |
2019-02-05 |
| 10010588 |
Methods of using pegylated interleukin-10 for treating hyperlipidemia |
John Brian Mumm |
2018-07-03 |